Please login to the form below

Not currently logged in
Email:
Password:

New accounts: April

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail websales@pmlive.com.

Eden Biodesign

N/A

Corporate

Affiniti (UK)

Ferring

Gonapeptyl and Norprolac

Fertility

MJL Advertising

Genzyme

Thyrogen

Oncology

Big Blue

Genzyme Therapeutics

Corporate

Corporate

Langland

Lilly

Corporate

Diabetes

PAN Advertising

Lilly

Humalog insulins and devices

Diabetes

PAN Advertising

Mencap

Corporate

Learning disabilities

MJL Advertising

Merck Pharma

Glucophage SR

Diabetes

PBC Comms

Novartis

Glivec

GI stomal tumour

PBC Comms

Novartis

Zometa

Bone metastases

PBC Comms

Novartis

Fortekor

CHF

MJL Advertising

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Otsuka Pharmaceuticals

Pletal

Pain

Brand(x)

Roche

Avastin

Colorectal cancer

MJL Advertising

sanofi-aventis

Taxotere

Oncology

Medicus London

sanofi-aventis

Arava

Arthritis

Medicus London

sanofi-aventis

Targocid

Anti-infective

Medicus London

sanofi-aventis

Xatral

Benign prostatic hyperplasia

Medicus London

sanofi-aventis

Tavanic

Anti-infective

Medicus London

Schering-Plough

Subutex

Opioid dependence

Medicus London

Schering-Plough

Viraferon-Peg

Hepatitis C

Medicus London

Solvay

Omacor

Cardiovascular

Life

 

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics